| For: | Suenaga Y, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y. Prognostic significance of perioperative tumor marker levels in stage II/III gastric cancer. World J Gastrointest Oncol 2019; 11(1): 17-27 [PMID: 30984347 DOI: 10.4251/wjgo.v11.i1.17] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v11/i1/17.htm |
| Number | Citing Articles |
| 1 |
Hüseyin Kocaaslan, Fatih Sümer. The impact of preoperative CEA and CA 19-9 levels on early and late postoperative outcomes in patients undergoing laparoscopic gastrectomy for gastric adenocarcinoma. Journal of Medicine and Palliative Care 2026; 7(2) doi: 10.47582/jompac.1860634
|
| 2 |
Xiao-Dong Zhu, Li-Xiang Zhang, Pan-Quan Luo, Hai Zhu, Zhi-Jian Wei, A-Man Xu. Prognostic significance of post-preoperative tumor markers increments in patients with non-metastatic gastric cancer. Journal of Cancer Research and Clinical Oncology 2023; 149(13) doi: 10.1007/s00432-023-05131-0
|
| 3 |
Fangyuan Zhang, Menglan Zhai, Jinru Yang, Lei Zhao, Zhenyu Lin, Jing Wang, Tao Zhang, Dandan Yu. ‘FLARE’ of tumor marker in advanced gastric cancer treated with first-line systemic therapy. Therapeutic Advances in Gastroenterology 2022; 15 doi: 10.1177/17562848221124029
|
| 4 |
Jun-Peng Lin, Jian-Xian Lin, Yu-Bin Ma, Jian-Wei Xie, Su Yan, Jia-Bin Wang, Jun Lu, Qi-Yue Chen, Xin-Fu Ma, Long-Long Cao, Mi Lin, Ru-Hong Tu, Chao-Hui Zheng, Ping Li, Chang-Ming Huang. Prognostic significance of pre- and post-operative tumour markers for patients with gastric cancer. British Journal of Cancer 2020; 123(3) doi: 10.1038/s41416-020-0901-z
|
| 5 |
Chang-Yue Zheng, Ju Wu, Chun-Sen Chen, Ze-Ning Huang, Yi-Hui Tang, Wen-Wu Qiu, Qi-Chen He, Guo-Sheng Lin, Qi-Yue Chen, Jun Lu, Jia-Bin Wang, Jian-Xian Lin, Long-Long Cao, Mi Lin, Ru-Hong Tu, Jian-Wei Xie, Ping Li, Chang-Ming Huang, Yu-Hui Zheng, Chao-Hui Zheng. A scoring model for predicting early recurrence of gastric cancer with normal preoperative tumor markers: A multicenter study. European Journal of Surgical Oncology 2023; 49(11) doi: 10.1016/j.ejso.2023.107094
|
| 6 |
Li-Li Shen, Hua-Long Zheng, Fang-Hui Ding, Jun Lu, Qi-Yue Chen, Bin-bin Xu, Zheng Xue, Jia Lin, Chang-Ming Huang, Chao-Hui Zheng. Delta computed tomography radiomics features-based nomogram predicts long-term efficacy after neoadjuvant chemotherapy in advanced gastric cancer. La radiologia medica 2023; 128(4) doi: 10.1007/s11547-023-01617-6
|
| 7 |
Chikashi Shibata, Toru Nakano, Akihiro Yasumoto, Atsushi Mitamura, Kentaro Sawada, Hitoshi Ogawa, Tomoya Miura, Ichiro Ise, Kazuhiro Takami, Kuniharu Yamamoto, Yu Katayose. Comparison of CEA and CA19-9 as a predictive factor for recurrence after curative gastrectomy in gastric cancer. BMC Surgery 2022; 22(1) doi: 10.1186/s12893-022-01667-z
|
| 8 |
Xi Yin Yang, Kaifeng Zhu, Qiang Hu. The order of surgery and chemotherapy matters: Multimodality therapy and stage‐specific differences in survival in gastric cancer. Journal of Surgical Oncology 2023; 127(3) doi: 10.1002/jso.27158
|
| 9 |
Shusuke Yagi, Koshi Kumagai, Souya Nunobe, Naoki Ishizuka, Toshifumi Yamaguchi, Yoshiro Imai, Masahiro Tsuda, Shusuke Haruta, Hiroki Fukunaga, Takanobu Yamada, Masahiro Goto. Risk factors for early recurrence after radical gastrectomy followed by adjuvant chemotherapy for stage II or III gastric cancer: a multicenter, retrospective study. Japanese Journal of Clinical Oncology 2024; 54(4) doi: 10.1093/jjco/hyad189
|
| 10 |
Fengcai Yan, Feng Shi, Xinbao Li, Hong Chang, Mulan Jin, Yan Li. Prognostic significance of CEA, Ki67 and p53 in pseudomyxoma peritonei of appendiceal origin. Journal of International Medical Research 2021; 49(6) doi: 10.1177/03000605211022297
|
| 11 |
Murat Güner, Tayfun Kaya, Cengiz Aydın. Does CA 125 Predict Peritoneal Dissemination in Patients with Gastric Cancer?. Indian Journal of Surgery 2022; 84(4) doi: 10.1007/s12262-021-03105-5
|
| 12 |
Fengming Luan, Shenbin Xu, Ke Chen, Kaibo Chen, Muxing Kang, Guofeng Chen, Jian Chen. Prognostic effect of CEA, AFP, CA19‑9 and CA242 for recurrence/metastasis of gastric cancer following radical gastrectomy. Molecular and Clinical Oncology 2024; 22(2) doi: 10.3892/mco.2024.2812
|
| 13 |
Zhen-Wu Qu, Yang Zhang, Ming-Yue Guo. Preoperative hypoalbuminemia as a prognostic factor in patients with gastric cancer undergoing radical gastrectomy: Construction of a nomogram. Journal of International Medical Research 2026; 54(6) doi: 10.1177/03000605261457301
|
| 14 |
Weiqiang You, Zerong Cai, Nengquan Sheng, Li Yan, Huihui Wan, Yongkun Wang, Jian Ouyang, Lu Xie, Xiaojian Wu, Zhigang Wang. Construction and Validation of Convenient Clinicopathologic Signatures for Predicting the Prognosis of Stage I-III Gastric Cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.848783
|
| 15 |
Vishnu Gopal, Yadav Nisha, Prasanth Ganesan, Smita Kayal, Zachariah Bobby, Subathra Adithan, Prasanth Penumadu, Vishnu P. Ramakrishnalay, Bhanu P. Bandlamudi, Arnab Bahttacharjee, Sindhu Dahagama, Biswajit Dubashi. Role of CYFRA 21-1 and CEA as prognostic and predictive markers in locally advanced and metastatic gastric carcinoma. Journal of Cancer Research and Therapeutics 2024; 20(5) doi: 10.4103/jcrt.jcrt_746_22
|
| 16 |
Yilin Tong, Yan Zhao, Zexing Shan, Jianjun Zhang. CA724 predicts overall survival in locally advanced gastric cancer patients with neoadjuvant chemotherapy. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-020-07666-8
|
| 17 |
Elisa Boldrin, Marcodomenico Mazza, Maria Assunta Piano, Rita Alfieri, Isabella Monia Montagner, Giovanna Magni, Maria Chiara Scaini, Loretta Vassallo, Antonio Rosato, Pierluigi Pilati, Antonio Scapinello, Matteo Curtarello. Putative Clinical Potential of ERBB2 Amplification Assessment by ddPCR in FFPE-DNA and cfDNA of Gastroesophageal Adenocarcinoma Patients. Cancers 2022; 14(9) doi: 10.3390/cancers14092180
|
| 18 |
Ai-Hua Sun, Xin-Yu Zhang, Yang-Yang Huang, Lei Chen, Qing Wang, Xiao-Cong Jiang. Prognostic value and predictive model of tumor markers in stage I to III gastric cancer patients. World Journal of Clinical Oncology 2024; 15(8): 1033-1047 doi: 10.5306/wjco.v15.i8.1033
|
| 19 |
Jin Moriyama, Yoko Oshima, Tatsuki Nanami, Takashi Suzuki, Satoshi Yajima, Fumiaki Shiratori, Kimihiko Funahashi, Hideaki Shimada. Prognostic impact of CEA/CA19-9 at the time of recurrence in patients with gastric cancer. Surgery Today 2021; 51(10) doi: 10.1007/s00595-021-02248-y
|
| 20 |
Tsinrong Lee, Thomas Zheng Jie Teng, Vishal G Shelat. Carbohydrate antigen 19-9 — tumor marker: Past, present, and future. World Journal of Gastrointestinal Surgery 2020; 12(12): 468-490 doi: 10.4240/wjgs.v12.i12.468
|
| 21 |
Yijia Lin, Huaxian Chen, Chengzhi Wei, Dandong Luo, Jianping Guo, Xiansheng Hu, Yinghan Chen, Junsheng Peng, Yongming Chen, Lei Lian. Tumor index predicts recurrences of patients with pathological stage Ⅰ gastric cancer after radical surgical resection. BMC Cancer 2025; 25(1) doi: 10.1186/s12885-025-15157-x
|
| 22 |
Koki Nakanishi, Chie Tanaka, Mitsuro Kanda, Kazushi Miyata, Kazuhiro Furukawa, Osamu Maeda, Dai Shimizu, Shizuki Sugita, Naomi Kakushima, Satoshi Furune, Hiroki Kawashima, Yuichi Ando, Tomoki Ebata, Yasuhiro Kodera. Low Expectancy of Conversion Surgery with R0 Resection in Patients with CEA > 5.0 ng/mL at the Initial RECIST Evaluation for Metastatic Gastric Cancer. Cancers 2023; 15(21) doi: 10.3390/cancers15215197
|
| 23 |
Shun Zhang, Jing-Ze Li, Tao Du, Hai-Qiang Li, Ren-Hao Hu, Chi-Ye Ma, Xi-Mao Cui, Chun Song, Xiao-Hua Jiang, Antonio Giovanni Solimando. The Modified Glasgow Prognostic Score Predicts Survival in Gastric Cancer Patients with Normal CEA and CA19-9. Canadian Journal of Gastroenterology and Hepatology 2022; 2022 doi: 10.1155/2022/3953004
|
| 24 |
Shanshan Bu, Siyi Wang, Ting Wang, Hang Xing, Yue Cao, Zhandong Zhang, Chuang Shang, Xiance Tang, Yifei Liu, Xiaoqun Dong, Xiushen Wang. Efficacy and safety of XELOX combined with neoadjuvant radiotherapy versus neoadjuvant chemotherapy in locally advanced gastric cancer. BMC Cancer 2025; 25(1) doi: 10.1186/s12885-025-14103-1
|